Literature DB >> 14192559

ASSAY OF UROKINASE PREPARATIONS WITH THE SYNTHETIC SUBSTRATE ACETYL-L-LYSINE METHYL ESTER.

S SHERRY, N ALKJAERSIG, A P FLETCHER.   

Abstract

Entities:  

Keywords:  ALCOHOL, METHYL; ARGININE; BIOLOGICAL ASSAY; EXPERIMENTAL LAB STUDY; LYSINE; STREPTODORNASE AND STREPTOKINASE

Mesh：

Substances：

Year:  1964        PMID： 14192559

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN： 0022-2143


× No keyword cloud information.
  7 in total

1.  Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. II. Evidence relating the kaolin-activated arginine esterase to plasma kallikrein.

Authors:  R W Colman; L Mattler; S Sherry
Journal:  J Clin Invest       Date:  1969-01       Impact factor: 14.808

2.  Urokinase therapy of subclavian-axillary vein thrombosis.

Authors:  R Zimmermann; H Mörl; J Harenberg; P Gerhardt; H M Kuhn; P Wahl
Journal:  Klin Wochenschr       Date:  1981-08-03

3.  [Fibrinolytic therapy of lower limb deep vein thrombosis with urokinase (author's transl)].

Authors:  R Zimmermann; J Harenberg; H Mörl; H M Kuhn; P Wahl; P Gerhardt
Journal:  Klin Wochenschr       Date:  1982-05-17

4.  [Detection and characterization of pregnancy proteins in the human placenta and their quantitative immunochemical determination in sera from pregnant women].

Authors:  H Bohn
Journal:  Arch Gynakol       Date:  1971-10-28

5.  Effect of urokinase antiserum on plasminogen activators: demonstration of immunologic dissimilarity between plasma plasminogen activator and urokinase.

Authors:  C S Kucinski; A P Fletcher; S Sherry
Journal:  J Clin Invest       Date:  1968-06       Impact factor: 14.808

6.  Partial purification and properties of a plasminogen activator from human erythrocytes.

Authors:  M Semar; L Skoza; A J Johnson
Journal:  J Clin Invest       Date:  1969-10       Impact factor: 14.808

7.  Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. I. Isolation and purification of plasma kallikreins.

Authors:  R W Colman; L Mattler; S Sherry
Journal:  J Clin Invest       Date:  1969-01       Impact factor: 14.808
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.